02:25 PM EDT, 10/23/2024 (MT Newswires) -- La Rosa Holdings ( LRHC ) reported on Wednesday preliminary nine-month revenue of roughly $45 million, increasing about 120% year-over-year.

The company also expects to achieve profitability next year and an annualized revenue run rate of $100 million by the end of 2024.

Shares soared 177% as intraday trading volume catapulted to over 165.4 million from a daily average of about 283,000.

Virax Biolabs ( VRAX ) shares soared 56% amid heavy trading after the company said Wednesday that its Cambridge Bioscience unit signed a distribution deal with Europa Biosite to commercialize Virax's ImmuneSelect Research Use portfolio in the UK and Ireland.

Over 82 million shares of Virax traded intraday versus a daily average of roughly 4.64 million.

Tevogen Bio ( TVGN ) said Wednesday that its artificial intelligence project, Tevogen AI, has joined Microsoft ( MSFT ) for Startups.

The partnership will provide Tevogen with "access to Microsoft's ( MSFT ) extensive ecosystem," the company said, adding it will accelerate the development of Tevogen's proprietary algorithms to advance the discovery and development of drugs.

Shares of Tevogen surged 56% as intraday trading volume advanced to more than 127.5 million from a daily average of about 11.3 million.

Price: 1.36, Change: +0.87, Percent Change: +176.87